Michael J. Klag, MD, MPH, from the Johns Hopkins Bloomberg School of Public Health joins the Medical Strategy Advisory Board (“MSAB”), expanding its expertise in public health, epidemiology and clinical research
SANTA MONICA, Calif.--(BUSINESS WIRE)--Doctor Evidence is pleased to announce the appointment of Michael J. Klag, MD, MPH to the MSAB. He joins Chair, Ameet Nathwani, MD, MRCP, DipPharmMed, MBA and members Calum MacRae, MB, ChB, PhD, BSc, Frank Rockhold, PhD, ScM, BA, and David Tovey, MD.
Dr. Klag, a world-renowned kidney disease epidemiologist, is Dean Emeritus and Second Century Distinguished Professor at the Johns Hopkins Bloomberg School of Public Health, Trustee of the Johns Hopkins Hospital, Trustee of the David & Lucile Packard Foundation, past Chair of the Association of Schools of Public Health and previous Chair of the NIH Advisory Board on Clinical Research. “Doctor Evidence is redefining what’s possible in healthcare technology and drug discovery and, ultimately, helping to develop more rapid and effective therapeutic interventions,” said Dr. Klag, “I look forward to engaging with the MSAB and the Doctor Evidence team to advance their platform and maximize its impact to improve patient outcomes, worldwide.”